These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 3338989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
    Craig PA, Olson ST, Shore JD.
    J Biol Chem; 1989 Apr 05; 264(10):5452-61. PubMed ID: 2925612
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects.
    Olson ST, Björk I.
    J Biol Chem; 1991 Apr 05; 266(10):6353-64. PubMed ID: 2007588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ.
    J Biol Chem; 1982 Dec 10; 257(23):13899-302. PubMed ID: 7142182
    [Abstract] [Full Text] [Related]

  • 7. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
    Verhamme IM, Bock PE, Jackson CM.
    J Biol Chem; 2004 Mar 12; 279(11):9785-95. PubMed ID: 14701814
    [Abstract] [Full Text] [Related]

  • 8. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST, Björk I, Sheffer R, Craig PA, Shore JD, Choay J.
    J Biol Chem; 1992 Jun 25; 267(18):12528-38. PubMed ID: 1618758
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
    Streusand VJ, Björk I, Gettins PG, Petitou M, Olson ST.
    J Biol Chem; 1995 Apr 21; 270(16):9043-51. PubMed ID: 7721817
    [Abstract] [Full Text] [Related]

  • 10. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME.
    J Biol Chem; 1983 Dec 10; 258(23):14708-17. PubMed ID: 6643505
    [Abstract] [Full Text] [Related]

  • 11. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST, Francis AM, Sheffer R, Choay J.
    Biochemistry; 1993 Nov 16; 32(45):12148-59. PubMed ID: 8218292
    [Abstract] [Full Text] [Related]

  • 12. Dependence of the rate of thrombin/antithrombin III reaction upon the turnover rate of a catalytic amount of heparin.
    Oshima G.
    Chem Pharm Bull (Tokyo); 1989 Aug 16; 37(8):2155-9. PubMed ID: 2598315
    [Abstract] [Full Text] [Related]

  • 13. Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.
    Verhamme IM.
    Anal Biochem; 2012 Feb 15; 421(2):489-98. PubMed ID: 22206940
    [Abstract] [Full Text] [Related]

  • 14. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    Hogg PJ, Jackson CM.
    J Biol Chem; 1990 Jan 05; 265(1):248-55. PubMed ID: 2294105
    [Abstract] [Full Text] [Related]

  • 15. Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction.
    Olson ST, Srinivasan KR, Björk I, Shore JD.
    J Biol Chem; 1981 Nov 10; 256(21):11073-9. PubMed ID: 7287752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF, Ellis V, Seno N, Kakkar VV.
    Biochem J; 1988 Sep 01; 254(2):547-51. PubMed ID: 2902851
    [Abstract] [Full Text] [Related]

  • 20. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH, Cunningham M, Nelsestuen GL.
    Biochim Biophys Acta; 1985 Jan 28; 838(1):106-13. PubMed ID: 2578296
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.